Changes in insulin-like growth factor-I and its binding proteins are associated with diabetes mellitus in older adults

Journal of the American Geriatrics Society

Volumn 63, Issue 5, 2015, Pages 902-909

  Aneke Nash, Chino S ^a   Parrinello, Christina M ^b   Rajpathak, Swapnil N ^c,d   Rohan, Thomas E ^a   Strotmeyer, Elsa S ^e   Kritchevsky, Stephen B ^f   Psaty, Bruce M ^g   Bůžková, Petra ^g   Kizer, Jorge R ^h   Newman, Anne B ^e   Strickler, Howard D ^a   Kaplan, Robert C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

diabetes mellitus; glycemic status; insulin like growth factor

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; GLUCOSE; INSULIN; INTERLEUKIN 6; ORAL ANTIDIABETIC AGENT; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; GLUCOSE BLOOD LEVEL;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; COHORT ANALYSIS; COMMUNITY LIVING; ENERGY EXPENDITURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; QUESTIONNAIRE; RETROSPECTIVE STUDY; SMOKING; WAIST CIRCUMFERENCE; ANALYSIS; BLOOD;

AGED; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; RETROSPECTIVE STUDIES;

EID: 84929616769     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13390     Document Type: Article

References (35)

1. Le Roith D,. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med 1997; 336: 633-640.
2. Jacob R, Barrett E, Plewe G, et al., Acute effects of insulin-like growth factor-I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin. J Clin Invest 1989; 83: 1717-1723.
3. Clemmons DR,. Role of insulin-like growth factor in maintaining normal glucose homeostasis. Horm Res Paediatr 2004; 62 (Suppl 1): 77-82.
4. Murphy LJ,. The role of the insulin-like growth factors and their binding proteins in glucose homeostasis. J Diabetes Res 2003; 4: 213-224.
5. Boulware SD, Tamborlane WV, Rennert NJ, et al., Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults. J Clin Invest 1994; 93: 1131-1139.
6. Moses AC, Young SC, Morrow LA, et al., Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes 1996; 45: 91-100.
7. Rajpathak SN, McGinn AP, Strickler HD, et al., Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults. Growth Horm IGF Res 2008; 18: 166-173.
8. Lee PD, Giudice LC, Conover CA, et al., Insulin-like growth factor binding protein-1: Recent findings and new directions. Proc Soc Exp Biol Med 1997; 216: 319-357.
9. George M, Ayuso E, Casellas A, et al., Beta cell expression of IGF-I leads to recovery from type 1 diabetes. J Clin Invest 2002; 109: 1153-1163.
10. Hugl SR, White MF, Rhodes CJ,. Insulin-like growth factor I (IGF-I)-stimulated pancreatic beta-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells. J Biol Chem 1998; 273: 17771-17779.
11. Ferrannini E, Gastaldelli A, Iozzo P,. Pathophysiology of prediabetes. Med Clin North Am 2011; 95: 327-339, vii-viii.
12. Newman AB, Arnold AM, Sachs MC, et al., Long-term function in an older cohort-the Cardiovascular Health Study All Stars Study. J Am Geriatr Soc 2009; 57: 432-440.
13. Fried LP, Borhani NO, Enright P, et al., The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1991; 1: 263-276.
14. Strotmeyer ES, Arnold AM, Boudreau RM, et al., Long-term retention of older adults in the Cardiovascular Health Study: Implications for studies of the oldest old. J Am Geriatr Soc 2010; 58: 696-701.
15. Cushman M, Cornell ES, Howard PR, et al., Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 1995; 41: 264-270.
16. Kaplan RC, McGinn AP, Pollak MN, et al., Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults. J Am Geriatr Soc 2008; 56: 652-660.
17. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011; 34 (Suppl 1): S11-S61.
18. Soares-Miranda L, Sattelmair J, Chaves P, et al., Physical activity and heart rate variability in older adults: The Cardiovascular Health Study. Circulation 2014; 129: 2100-2110.
19. Sandhu MS, Heald AH, Gibson JM, et al., Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: A prospective observational study. Lancet 2002; 359: 1740-1745.
20. Vaessen N, Heutink P, Janssen JA, et al., A polymorphism in the gene for IGF-I: Functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001; 50: 637-642.
21. Rajpathak SN, He M, Sun Q, et al., Insulin-like growth factor axis and risk of type 2 diabetes in women. Diabetes 2012; 61: 2248-2254.
22. Brugts MP, van Duijn CM, Hofland LJ, et al., Igf-I bioactivity in an elderly population: Relation to insulin sensitivity, insulin levels, and the metabolic syndrome. Diabetes 2010; 59: 505-508.
23. Leung KC, Doyle N, Ballesteros M, et al., Insulin regulation of human hepatic growth hormone receptors: Divergent effects on biosynthesis and surface translocation. J Clin Endocrinol Metab 2000; 85: 4712-4720.
24. Ji S, Guan R, Frank SJ, et al., Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway. J Biol Chem 1999; 274: 13434-13442.
25. Xu J, Ji S, Venable DY, et al., Prolonged insulin treatment inhibits GH signaling via STAT3 and STAT1. J Endocrinol 2005; 184: 481-492.
26. Gibson JM, Westwood M, Crosby SR, et al., Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1995; 80: 1369-1375.
27. Lewitt MS, Hall K, Bang P, et al., Altered response of insulin-like growth factor-binding protein 1 to nutritional deprivation in type 2 diabetes mellitus. Metabolism 2005; 54: 275-280.
28. Kaplan RC, McGinn AP, Pollak MN, et al., High insulinlike growth factor binding protein 1 level predicts incident congestive heart failure in the elderly. Am Heart J 2008; 155: 1006-1012.
29. Kaplan RC, Buzkova P, Cappola AR, et al., Decline in circulating insulin-like growth factors and mortality in older adults: Cardiovascular health study all-stars study. J Clin Endocrinol Metab 2012; 97: 1970-1976.
30. Nguyen KH, Yao XH, Moulik S, et al., Human IGF binding protein-3 overexpression impairs glucose regulation in mice via an inhibition of insulin secretion. Endocrinology 2011; 152: 2184-2196.
31. Kaplan RC, McGinn AP, Pollak MN, et al., Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. J Clin Endocrinol Metab 2007; 92: 1319-1325.
32. Vitale G, Brugts MP, Ogliari G, et al., Low circulating IGF-I bioactivity is associated with human longevity: Findings in centenarians' offspring. Aging (Albany NY) 2012; 4: 580-589.
33. Norby FL, Wold LE, Duan J, et al., IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am J Physiol Endocrinol Metab 2002; 283: E658-E666.
34. Seigel GM, Lupien SB, Campbell LM, et al., Systemic IGF-I treatment inhibits cell death in diabetic rat retina. J Diabetes Complications 2006; 20: 196-204.
35. Bacha F, Arslanian SA,. Ghrelin suppression in overweight children: A manifestation of insulin resistance? J Clin Endocrinol Metab 2005; 90: 2725-2730.